KIDS Earnings Date: Feb 25, 2027 (Estimated) — OrthoPediatrics Corp.
NASDAQ · Healthcare · Medical Devices
Updated
When is KIDS's next earnings date?
OrthoPediatrics Corp. (KIDS) is expected to report Q4 2026 earnings on Thursday, February 25, 2027 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.20 on revenue of $68.6M.
How did KIDS do in its last earnings report?
In its most recent report on Oct 27, 2026 (Q3 2026), OrthoPediatrics Corp. posted EPS of -$0.23 versus the -$0.21 estimate, a miss of 7.3%. Revenue was $72.7M against a $68.5M estimate. The stock's 1-day post-earnings move was +29.3%.
How much does KIDS stock move after earnings?
KIDS beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 10.6% (up or down) in the day after earnings.
About OrthoPediatrics Corp.
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
🤖 AI Earnings Analysis
OrthoPediatrics cleared its PNP Femur Retrograde Nail and completed first implants, while raising 2026 guidance—an encouraging product catalyst. Q3 revenue rose 19% to $72.7M, beating estimates, though a 16.8% operating loss tempers the result.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-27 | Q3 2026 | -0.21 | -0.23 | -7.33% | $72.7M | ❌ Miss | +29.30% | — | — |
| 2026-08-04 | Q2 2026 | -0.29 | -0.26 | +10.34% | $70.5M | ✅ Beat | +6.85% | +16.09% | +9.20% |
| 2026-04-30 | Q1 2026 | -0.43 | -0.42 | +2.33% | $59.4M | ✅ Beat | +3.78% | +16.67% | +10.56% |
| 2026-02-26 | Q4 2025 | -0.32 | -0.26 | +18.75% | $61.6M | ✅ Beat | +7.76% | +0.17% | -12.76% |
| 2025-10-28 | Q3 2025 | -0.25 | -0.24 | +4.00% | $61.3M | ✅ Beat | -2.66% | -1.95% | +9.93% |
| 2025-08-05 | Q2 2025 | -0.24 | -0.11 | +54.17% | $61.1M | ✅ Beat | -11.34% | -2.87% | +2.58% |
| 2025-03-04 | Q4 2024 | -0.26 | -0.29 | -11.54% | $52.7M | ❌ Miss | +11.88% | +12.36% | +14.94% |
| 2024-11-06 | Q3 2024 | -0.24 | -0.18 | +25.00% | $54.6M | ✅ Beat | -11.18% | -21.62% | -25.14% |
Showing last 8 quarters.
Revenue by segment & region
By segment
Q3 FY26 · $72.7M total
| Segment | Share | Revenue | YoY | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| Trauma And Deformity | 72.4% | $52.6M | +19.2% | $37.9M | $41.7M | $44.1M | — |
| Spine | 26.4% | $19.2M | +17.9% | $13.7M | $18.5M | $16.3M | $17.6M |
| Sports Medicine And Other | 1.2% | $866K | +2.4% | $880K | $905K | $846K | $1.4M |
By region
Q3 FY26 · $72.7M total
| Segment | Share | Revenue | YoY | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|---|---|---|---|
| UNITED STATES | 79.7% | $57.9M | +18.8% | $40.9M | $48.1M | $48.7M | $48.6M |
| Non-US | 20.3% | $14.8M | +17.9% | $11.5M | $12.9M | $12.5M | $13.0M |
Source: company filings via FMP. YoY compares the same fiscal period a year earlier.